“Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome”, Front Pediatr, vol. 3, 2015.
, , “Tangency Outcomes for Clinical Trials”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Algorithms for Inference Following Bernoulli Random Walks with Desirable Absorbing Boundaries”, in Society for Clinical Trials Annual Meeting, Boston, MA, 2013.
, “Estimating Death Rates In Substance Use Disorder”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
, “Rationale for Using Exercise in the Treatment of Stimulant Use Disorders. Journal of Global Drug Policy and Practice”, J Drug Policy & Prac, vol. 6, p. 33, 2012.
, “Study Design to Examine the Potential Role of Assessment Reactivity in Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED) Protocol”, Addict Sci Clin Pract, vol. 7, p. 16, 2012.
, “Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10”, Ophthalmology, vol. 118, pp. 345-352, 2011.
, “Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)”, Am J Drug Alcohol Abuse, vol. 37, pp. 417-425, 2011.
, “Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials”, Am J Drug Alcohol Abuse, vol. 37, pp. 350-357, 2011.
, “SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion”, Ophthalmology, vol. 118, pp. 1364-1372, 2011.
, “Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial”, Trials, vol. 19, pp. 206-231, 2011.
, “SCORE Study Report 8: Closed Tests for All Pairwise Comparisons of Means”, Drug Inf J, vol. 44, pp. 405-420, 2010.
, “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Stereoscopic Color Fundus Photographs and Fluorescein Angiograms: SCORE Study Report 9”, Archives of Ophthalmology, vol. 128, pp. 1140-1145, 2010.
, “A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion [..] (SCORE) Study Report 6”, Arch Ophthalmol, vol. 127, pp. 1115-1128, 2009.
, “A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion: The SCORE Study Report 5”, Arch Ophthalmol, vol. 127, pp. 1101-1114, 2009.
, “SCORE Study Report 2: Interobserver Agreement Between Investigator and Reading Center Classification of Retinal Vein Occlusion Type”, Ophthalmology, vol. 116, pp. 756-761, 2009.
, “SCORE Study Report 3: Study Design and Baseline Characteristics”, Ophthalmology, vol. 116, pp. 1770-1777 e1, 2009.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4”, Arch Ophthalmol, vol. 127, pp. 1461-1467, 2009.
, “Association Between Center Point Thickness and Visual Acuity in SCORE Study Patients With Macular Edema Due to Retinal Vein Occlusion”, in American Academy of Ophthalmology Annual Meeting, Atlanta, GA, 2008.
, “Closed Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study”, presented at the 04/2008, St. Louis MO, 2008.
, “Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort”, Arch Neurol, vol. 65, pp. 1096-1101, 2008.
, “Proc Sql for Exact Testing Trend in Proportions”, in South East SAS Users Group, St. Petersburg Beach, FL, 2008.
, , “The SCORE Study: Design and Baseline Characteristics”, in American Academy of Ophthalmology Annual Meeting, Atlanta, GA, 2008.
,